CommPro.Biz: “We Hate the Phrase “New Normal” But Here are 7 Marketing Tips for Navigating the You-Know-What” (Dec. 5, 2022)
Pharmaceutical Technology: “Coronavirus company news summary- France drops Merck’s anti-Covid-19 pill order- BiondVax signs deal for nanosized Covid-19 therapy”
The Late Late Show with James Corden: “A Company in Massachusetts has created a new type of tattoo ink”
Pharmaceutical Technology: “Coronavirus company news summary – Akston Biosciences announces positive Phase I results for Covid-19 vaccine candidate – Pfizer and BioNTech provide update on Covid-19 vaccine booster programme”
Akston Bioscience: “Akston Biosciences Announces Commercial Supply Agreement of Seppic’s Adjuvant to Formulate Akston Shelf-stable COVID-19 Vaccine at Global Scale;New data shows protein-based AKS-452 vaccine is shelf-stable for six months at 25° C (77° F)”
Canadian Manufacturing: “Vortex International names Sylvain Dugas as new COO:Dugas will be responsible for the company’s operations with a focus on optimizing operational efficiency and organizational capability as Vortex continues to grow”
Opera News: “Akston Biosciences Announces Commercial Supply Agreement of Seppic’s Adjuvant to Formulate Akston Shelf-Stable COVID-19 Vaccine at Global Scale”
Net.hr: “The Second Generation is Coming: What changes do the new corona vaccines bring?”
RepublicWorld.com (India): “Akston Biosciences Launches Phase I/II Clinical Trial Of Second-Generation COVID-19 Vaccine: Akston Biosciences Corporation, a developer of new classes of biologic therapeutics, announced today that the first participants have been dosed in an open-label trial of AKS-452, its COVID-19 vaccine candidate”
Meanwhile Bad News in NH After a Newspaper Closes
While News: “India starts trial of US firm’s second-generation Covid vaccine | India News”
Network News Program Adapts to the Web